CB2 cannabinoid receptor induction in experimental stroke

被引:0
|
作者
Jin, KL [1 ]
Mao, XO [1 ]
Goldsmith, PC [1 ]
Greenberg, DA [1 ]
机构
[1] Buck Ctr Res Aging, Special Res Program, Novato, CA 94948 USA
关键词
D O I
10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cannabinoids protect cortical neurons from ischemic injury by interacting with CB1 receptors. Because a variety of neuroprotective genes are induced in cerebral ischemia, we examined the effect of experimental stroke, produced by 20 minutes of middle cerebral artery occlusion in rats, on CB1 receptor expression. Western blotting and immunohistochemistry showed that CBI expression on neurons was increased in the arterial boundary zone of the cortical mantle, beginning by 2 hours and persisting for 72 hours or more after ischemia These findings are consistent with a neuroprotective role for endogenous cannabinoid signaling pathways and with a potential therapeutic role in stroke for drugs that activate CB1 receptors.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [1] Induction of cannabinoid cb2 receptor positive cells in the brain by stroke
    Ashton, J. C.
    Glass, M.
    Sutherland, B.
    Rahman, R.
    Appleton, I
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 65 - 66
  • [2] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    FASEB JOURNAL, 2019, 33
  • [3] Role of the cannabinoid CB2 receptor in the development of experimental autoimmune encephalomyelitis
    Palazuelos, J.
    Hatterer, E.
    Julien, B.
    Guzman, M.
    Nataf, S.
    Davoust, N.
    Galve-Roperh, I.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 : 58 - 58
  • [4] CB2: a cannabinoid receptor with an identity crisis
    Atwood, Brady K.
    Mackie, Ken
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 467 - 479
  • [5] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    PAIN, 2006, 122 (1-2) : 36 - 42
  • [6] Brain Cannabinoid CB2 Receptor in Schizophrenia
    Ishiguro, Hiroki
    Horiuchi, Yasue
    Ishikawa, Maya
    Koga, Minori
    Imai, Keiko
    Suzuki, Yoshimi
    Morikawa, Miyuki
    Inada, Toshiya
    Watanabe, Yuichiro
    Takahashi, Makoto
    Someya, Toshiyuki
    Ujike, Hiroshi
    Iwata, Nakao
    Ozaki, Norio
    Onaivi, Emmanuel S.
    Kunugi, Hiroshi
    Sasaki, Tsukasa
    Itokawa, Masanari
    Arai, Makoto
    Niizato, Kazuhiro
    Iritani, Shyuji
    Naka, Izumi
    Ohashi, Jun
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Arinami, Tadao
    BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 974 - 982
  • [7] Targeting the CB2 cannabinoid receptor in osteoporosis
    Bab, Itai
    Ofek, Orr
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (02) : 135 - 138
  • [8] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
  • [9] Cannabinoid 2 (CB2) receptor upregulation in experimental autoimmune uveitis (EAU)
    Ben-David, Gil
    Nisgav, Yael
    Weinberger, Yehonatan
    Kramer, Michal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [10] Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis
    Storr, Martin A.
    Keenan, Catherine M.
    Zhang, Hong
    Patel, Kamala D.
    Makriyannis, Alexandros
    Sharkey, Keith A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (11) : 1678 - 1685